Any current/future new fundraising through debt or equity?

There were no explicit mentions of any current or planned fundraising through debt or equity during the Q3 FY '26 earnings call. Management focused on integration and growth of acquisitions like Comfort Click and RiteBite rather than new capital raising. No questions or responses indicated upcoming capital raising activities. The company is optimistic about financial performance with EBITDA and PAT improvements expected from next financial year onwards. They are monitoring the business and evaluating opportunities, but no immediate plans for fundraising were shared. The management emphasized m

Any current/future capex/capital investment/strategic investment?

No explicit mention of current or near-future capital expenditure or strategic investments was detailed in the provided transcript of the Zydus Wellness Limited call. The focus was on integration, growth, and evaluation of acquired businesses (Comfort Click and RiteBite), including long-term incentive programs for critical talent. Expansion plans emphasized growing existing Comfort Click markets in Europe and entering new markets like the U.S., Poland, Finland, and UAE. New product launches and distribution expansion efforts were highlighted, especially for RiteBite, including RTD (Ready to Dr

Future growth expectations in sales/revenue/volumes?

Comfort Click aims for continued double-digit top-line growth, driven primarily by deepening penetration in existing European markets and expansion into new markets like the U.S., Poland, Finland, and UAE. The Max Protein business aspires to reach INR 500 crores revenue in about 2 years, indicating strong growth potential. Base business (excluding Comfort Click and RiteBite) has registered double-digit volume growth. Overall international business, led by Comfort Click and other entities, forms about one-third of revenue with potential to grow larger. Distribution expansion, product portfolio

Future growth expectations in earnings/operating earnings/profits/EPS?

Current financial year FY2026 expected to be the bottom for earnings due to acquisition-related costs and amortization. From FY2027 onwards, profitability and EPS expected to be accretive, including for newly acquired entities. Comfort Click projected to grow top line in good double-digits with sustainable EBITDA margins of 14%+. Base business aims to improve EBITDA margins to 16%-18% over next 1-2 years. The consolidated EBITDA margin improved to 6.3% in Q3 FY2026 from 3.2% YoY, showing margin expansion potential. Strong growth in organic businesses, double-digit volume growth exclu

IN US

Sale is live|00:00:00left today

Zydus Wellness LtdQ4 FY27Food Products

Zydus Wellness Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹534P/E: 66.5Market Cap: ₹16.0K CrSector: Food Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→Comfort Click aims for continued double-digit top-line growth, driven primarily by deepening penetration in existing European markets and expansion into new markets like the U.S., Poland, Finland, and UAE.
→The Max Protein business aspires to reach INR 500 crores revenue in about 2 years, indicating strong growth potential.
→Base business (excluding Comfort Click and RiteBite) has registered double-digit volume growth.
→Overall international business, led by Comfort Click and other entities, forms about one-third of revenue with potential to grow larger.
→Distribution expansion, product portfolio expansion, and increased sell-through through existing outlets are key growth levers.
→Growth is supported by increasing repeat purchase rates and expanding brand presence across various channels, including e-commerce and institutional sales.
→Organic business seasonality typically strong from January to June, with demand in early quarter 1 in line with expectations.

Margin guidance

Category 3

→Current financial year FY2026 expected to be the bottom for earnings due to acquisition-related costs and amortization.
→From FY2027 onwards, profitability and EPS expected to be accretive, including for newly acquired entities.
→Comfort Click projected to grow top line in good double-digits with sustainable EBITDA margins of 14%+.
→Base business aims to improve EBITDA margins to 16%-18% over next 1-2 years.
→The consolidated EBITDA margin improved to 6.3% in Q3 FY2026 from 3.2% YoY, showing margin expansion potential.
→Strong growth in organic businesses, double-digit volume growth excluding acquisitions.
→RiteBite Max Protein business moving from breakeven at acquisition to nearing double-digit EBITDA margins, with ambitions to reach INR500 crore revenue in ~2 years.
→New product launches, geographic expansions, and seasonal opportunities expected to provide incremental growth momentum into 2026 and beyond.

3 more insights locked — sign up free to unlock

Fundraise plans

→There were no explicit mentions of any current or planned fundraising through debt or equity during the Q3 FY '26 earnings call.
→Management focused on integration and growth of acquisitions like Comfort Click and RiteBite rather than new capital raising.
→No questions or responses indicated upcoming capital raising activities.
→The company is optimistic about financial performance with EBITDA and PAT improvements expected from next financial year onwards.
→They are monitoring the business and evaluating opportunities, but no immediate plans for fundraising were shared.
→The management emphasized maintaining steady operations and growth rather than discussing financing plans at this stage.

Order book

The transcript provided from Zydus Wellness Limited's Q3 FY2026 earnings call does not contain any specific information related to current or expected orderbook or pending orders. The discussion primarily focuses on: - Business priorities and market focus, especially Comfort Click's expansion in developed markets. - Talent retention and long-term incentive plans. - Margin disclosures and financial performance related to acquisitions. - Growth strategies for Max Protein and Comfort Click. - Investment and seasonality impacts on base business margins. - Discussions on improving segmental disclosures for better tracking. No explicit details or figures regarding orderbook status or pending orders were mentioned in the available pages.

Capex plans

Yes

→No explicit mention of current or near-future capital expenditure or strategic investments was detailed in the provided transcript of the Zydus Wellness Limited call.
→The focus was on integration, growth, and evaluation of acquired businesses (Comfort Click and RiteBite), including long-term incentive programs for critical talent.
→Expansion plans emphasized growing existing Comfort Click markets in Europe and entering new markets like the U.S., Poland, Finland, and UAE.
→New product launches and distribution expansion efforts were highlighted, especially for RiteBite, including RTD (Ready to Drink) products and sharp, focused distribution in top cities.
→Management indicated ongoing evaluation of international expansion priorities, particularly regarding India, but no immediate plans or capex commitments were confirmed.
→Disclosure improvements and better reporting metrics on segmental performance are planned by year-end, reflecting strategic focus on transparency rather than capital investment.

How does Zydus Wellness Ltd rank vs peers in Food Products?

Pro feature

1Zydus Wellness Ltd

Rev 3Mar 3

See full Food Products sector rankings

Want more stocks like Zydus Wellness Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio